Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Phase I

This is a first-in-human open-label Phase 1/2a study to evaluate the safety, tolerability,
pharmacokinetics, pharmacodynamics, and preliminary clinical activity of 23ME-00610 given by
intravenous infusion in patients with advanced solid malignancies who have progressed on all
available standard therapies
Phase I
I
Berlin, Jordan
NCT05199272
VICCPHI2268

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.